InvestorsHub Logo

Just the facts maam

01/22/23 10:06 AM

#14135 RE: silvr_surfr #14134

Makes sense Silvr. Anyhow, at least one 505(b)(2) is expected this year, as they project starting earnout payments in 2023. I imagine it will be for a stable oral liquid composition of Terazosin.

Just the facts maam

01/22/23 10:10 AM

#14136 RE: silvr_surfr #14134

Silvr. looks like Pfizer loses IP protection in 2026 in the EU. I can see a Merck partnership for the EU in 2026.

Pfizer Presentation. Slide 4 shows LOE

Just the facts maam

01/22/23 10:10 AM

#14137 RE: silvr_surfr #14134

Silvr. looks like Pfizer loses IP protection in 2026 in the EU. I can see a Merck partnership for the EU in 2026.

Pfizer Presentation. Slide 4 shows LOE